Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EPS accelerators

EPS accelerators

Company 1Q04EPS est 1Q04EPS actual Outcome Growth from 1Q03 5/7 cls Wk chg % chg Mcap chg 5/7 Mcap
Axcan (A) $0.23 $0.24

Read the full 263 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE